KRAS4A to KRAS4B expression ratios are influenced by two factors: the type of tumor under investigation (lung, pancreatic, or colorectal cancer) and whether the surrounding tissue is malignant or normal. The gene discussed is KRAS; the disease is colorectal cancer.